期刊文献+

紫杉醇与多烯紫杉醇对小鼠卵巢储备能力的影响 被引量:1

Effects of Paclitaxel and Docetaxel on Ovarian Reserve Capacity in Mice
原文传递
导出
摘要 目的:探索多次重复小剂量紫杉醇与多烯紫杉醇对小鼠卵巢储备功能的影响。方法:30只昆明雌性小鼠随机分组,即对照组(生理盐水0.2 ml/d×20 d)、紫杉醇组[紫杉醇注射液6.0 mg/(kg·d)×20 d]、多烯紫杉醇组[多西他赛注射液1.5 mg/(kg·d)×13 d],每组10只,用药期间每日观察小鼠的一般情况、动情周期,用药结束后观察小鼠血清FSH、E2水平、卵巢质量、形态结构和各级卵泡数的变化。结果:用药结束后紫杉醇组FSH水平(54.59±12.73 pg/ml)高于对照组(31.85±9.82 pg/ml),E2水平(27.39±9.36 pg/ml)低于对照组(55.26±13.41 pg/ml),差异有统计学意义(P<0.05);而多烯紫杉醇组FSH(33.27±5.91 pg/ml)、E2(49.56±3.57 pg/ml)变化较对照组不明显,差异无统计学意义(P>0.05);紫杉醇组FSH、E2水平变化较多烯紫杉醇组差异有统计学意义(P<0.05)。紫杉醇组小鼠的总卵泡数(598±159个)和卵巢质量(7±2 mg)与对照组小鼠(1 243±137个,27±6 mg)比较,差异均有统计学意义(P<0.05);多烯紫杉醇组小鼠的总卵泡数(1 143±130个)和卵巢质量(22±5 mg)与对照组小鼠比较,差异均无统计学意义(P>0.05);小鼠的总卵泡数和卵巢质量组间差异均有统计学意义(P<0.05)。结论:多次重复小剂量紫杉醇与多烯紫杉醇对卵巢储备功能均有不同程度的影响,其中紫杉醇影响更为严重。 Objective: To study the effect of repeated small doses of paclitaxel and docetaxel on the ovarian reserve. Methods: Thirty female KM mice were randomly divided into three groups: control group (NS 0.2 ml/d, for 20 d, i.p), paclitaxel group [6.0 mg/(kg.d), for 20 d, i.p], and docetaxel group [1.5 mg/(kg.d), for 13 d, i.p]. Body weight, estrous cycle daily during treatment, and FSH, E2 levels in serum, ovarian weight, histopathology,the number of follicles after treatment were measured, then those indicators were cpmpared among the three groups. Results: After treatment, there were significant differences between paclitaxel group and control group in serum levels of FSH and E2 (54.59 ±12.73 pg/ml vs 31.85 ± 9.82 pg/ml and 27.39 ± 9.36 pg/ml vs 55.26 ± 13.41 pg/ml), P〈0.05 for both comparisons. But there were no significant differences of serum FSH (33.27±5.91 pg/ml) and E2 (49.56±3.57 pg/ml) levels in docetaxel group compared with those of control group. There were significant differences between paclitaxel group and docetaxel group in both FSH and E2 levels in serum.There were significant differences between paclitaxel group and control group in two levels as follows: the total number of follicles (598 ± 159 vs 1 243±137) and the weight of ovaries (7 ± 2 mg vs 27 ± 6 mg). But there were no significant differences in the total number of follicles (1 143 ±130) and the weight of ovaries (22 ± 5 mg) in docetaxel group compared with those of control group. There were significant differences between paclitaxel group and docetaxel group in the total number of follicles and the weight of ovaries. Conclusion: Repeated small doses of paclitaxel and docetaxel impact the ovarian reserve function in different extent, the effect of paclitaxel was more serious.
出处 《生殖与避孕》 CAS CSCD 2014年第5期349-353,共5页 Reproduction and Contraception
关键词 紫杉醇 多烯紫杉醇 卵巢储备功能 化疗 小鼠 paclitaxel docetaxel ovarian reserve function chemotherapy mice
  • 相关文献

参考文献11

  • 1Molina JR, Barton DL, Loprinzi CL. Chemotherapy inducedovarian failure (Manife station and management). Drug Satey,2005, 28(5):401-6.
  • 2Maltaris T, Seufert R, Fischi F, et al. The effect of cancertreatment on female fertility and strategies for preservingfertility. Eur J Obstet Gynecol Reprod Biol, 2007, 130(2):148-55.
  • 3Blumenfeld Z. Ovarian function preservation by GnRHagonists during chemother apy. J Womens Health (Larehmt),2009, 18(9):1471-3.
  • 4Montemurro F, Choa G, Faggiuolo R, et al. Safety and activityof docetaxel and trastuzumab in HER2 overexpressing metastaticbreast cancer: a pilot phase II study. Am J Clin Oncol,2003, 26(1):95-7.
  • 5Gucer F, Balkanli-Kaplan P, Doganay L, et al. Effect ofpaclitaxel on primordial follicular reserve in mice. Fertil Steril, 2001, 76(3):628-9.
  • 6Ataya K, Rao LV, Lawrence E, et al. Luteinizing homonereleasing homone agonist inhibits cyclophamide-induce ovarianfollicular depletion in rhesus monkey. Biol Reprod, 1995,52(2):365-72.
  • 7Guastalla JP, Dieras V. The taxanes: toxicity and quality oflife considerations in advanced ovarian cancer. Br J Cancer,2003, 89(3):16-22.
  • 8杨孝来.紫杉醇与多烯紫杉醇[J].实用药物与临床,2010,13(4):281-283. 被引量:16
  • 9Oosterhuis GJ, Vermes I, Michgelsen HW, et al. Folliclestimulating hormone measured in unextracted urine throughoutthe menstrual cycle correlates with age and ovarianreserve. Hum Reprod, 2002, 17(3):641-6.
  • 10Meirow D, Lewis H, Nugent D, et al. Subclinical depletion ofprimordial follicular reserve in mice treated with cyclophosphamide:clinical importance and proposed accurateinvestigative tool. Hum Reprod, 1999, 14(7):1903-7.

二级参考文献28

  • 1朱宇泽,王军,高建飞,饶智国,张新华,杜光祖.卡培他滨联合多西紫杉醇与L-OHP+5-FU+LV方案治疗晚期胃癌近期疗效对比研究[J].实用医学杂志,2006,22(6):709-711. 被引量:7
  • 2戴文清,吴海鹰,刘俊玲.多西紫杉醇联合顺铂2周方案治疗晚期非小细胞肺癌临床观察[J].中国医药,2006,1(5):290-292. 被引量:5
  • 3郭振昌,沈存芳.应用多西紫杉醇出现全身皮肤黑色素沉着1例报告[J].中国医药,2006,1(10):640-640. 被引量:1
  • 4Luca G,Christine M,Antonio G,et al.Nonlinear pharmacokinetics and metabolism of paclitaxel and its pharmacokinetic/pharmacodynamic relationships in human[J].J Clin Oncol,1995,13(1):180.
  • 5Viganol L,Locatelli A,Graelli G,et al.Drug interaction of paclitaxel and docetaxel and their relevance for the design of combination chemotherapy[J].New Drugs,2001,19(2):179-196.
  • 6Gradishar WJ,Tjulandin S,Davidson N,et al.Phase Ⅲ trial of nanoparticle albumin-bound paclitaxel with polyethylated castor oil-based paclitaxel in women with breast cancer[J].J Clin Oncol,2005,23(31):7794-7803.
  • 7Crown J,O′leary M,Wei-Seong O.Docetaxel and paclitaxel in treatment of breast cancer:a review of clinical experience[J].Oncologist,2004,9(suppl.2):24-32.
  • 8Baker AF,Dorr RT.Drug interactions with the taxanes:clinical implications[J].Cancer Treat Rev,2002,27(4):221-223.
  • 9Eisenhauer EA,Vermorken JB.The Taxoids:comparative clinical pharmacology and therapeutic potential[J].Drugs,1998,55(1):5-30.
  • 10Ghersi D,Wilcken N,Simers RJ.A systematic review of taxane-containing regimens for metatic breast cancer[J].Br J Cancer,2005,93(3):293-301.

共引文献22

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部